Venus Acquisition Corporation Warrant
VENAW
VENAW was delisted on the 9th of December, 2022.
14 hedge funds and large institutions have $1.14M invested in Venus Acquisition Corporation Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
3% less capital invested
Capital invested by funds: $1.18M → $1.14M (-$34K)
13% less funds holding
Funds holding: 16 → 14 (-2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
-$3K |
VENAW Hedge Fund Activity: Q3 2022 in Review
14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Venus Acquisition Corporation Warrant (VENAW) for Q3 2022, worth a combined $1.14M — down 2.9% from $1.18M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VENAW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was HRT Financial, adding an estimated $10. The largest seller was MYDA Advisors, exiting entirely with an estimated $3K sold.
- 14 institutional investors held Venus Acquisition Corporation Warrant (VENAW) as of Q3 2022, down from 16 in Q2 2022.
- Funds reported $1.14M of Venus Acquisition Corporation Warrant stock for Q3 2022, down 2.9% quarter-over-quarter.
- 0 funds opened new Venus Acquisition Corporation Warrant positions in Q3 2022 and 2 closed out, a net change of -2 holders.
- The largest Venus Acquisition Corporation Warrant buyer in Q3 2022 was HRT Financial, an estimated $10 added.
- The largest Venus Acquisition Corporation Warrant seller in Q3 2022 was MYDA Advisors, an estimated $3K sold.
Based on aggregated 13F filings for Q3 2022.